PlexusDx offers GLP-Squared Injection, which combines semaglutide and tirzepatide for dual-pathway activation, at $289/mo month-to-month, or from $249/mo on the 6-month plan
It helps manage the skins barrier function, retaining moisture, and managing hydration levels
Wegovy is FDA-approved only for people who meet the minimum BMI criteria because: It was tested in clinical trials for people classified as overweight or obese The risk/benefit balance is considered appropriate only for these populations Thats why your doctor will calculate your BMI before prescribing Wegovy and check for related health risks
Andreas Birkenfeld, PLID, Mitautor der Studie
Tirzepatide/B6 vial April 3, 2025 Tirzepatide/B12 or Tirzepatide/Glycine vial April 3, 2025 Tirzepatide/B6 vial $0.00 Tirzepatide/B6 vial and syringes